Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2
作者：
Song, Jiho [1 ]
Lee, Jung Wook [1 ]
Chung, Shin Hyuck [1 ]
Wenas, Michelle A. [1 ]
Min, Kyung Hoon [1 ]
机构：
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;
D O I：
10.1002/bkcs.11278
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1255 / 1256
页数：2
相关论文
共 50 条
  • [1] New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
    Mostafa, Yaser A.
    Assoud, Jalil Abdeljalil
    Desoky, Ahmed Y.
    Mohamady, Samy
    Mohamed, Nesma M.
    Salem, Ola I. A.
    Almarhoon, Zainab M.
    Braese, Stefan
    Youssif, Bahaa G. M.
    FRONTIERS IN CHEMISTRY, 2024, 12
  • [2] A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
    Yousefbeyk, Fatemeh
    Ghasemi, Saeed
    PHARMACEUTICAL SCIENCES, 2025, 31 (01) : 43 - 64
  • [3] Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERα/VEGFR-2 ligands with anti-breast cancer activity
    Luo, Guoshun
    Tang, Zhichao
    Lao, Kejing
    Li, Xinyu
    You, Qidong
    Xiang, Hua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 783 - 795
  • [4] [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
    Garofalo, Antonio
    Goossens, Laurence
    Lemoine, Amelie
    Ravez, Severine
    Six, Perdue
    Howsam, Michael
    Farce, Amaury
    Depreux, Patrick
    MEDCHEMCOMM, 2011, 2 (01) : 65 - 72
  • [5] Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors
    Zhang, Hai-Qi
    Gong, Fei-Hu
    Li, Chuan-Gui
    Zhang, Chi
    Wang, Yan-Jie
    Xu, Yun-Gen
    Sun, Li-Ping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 371 - 379
  • [6] Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
    de Castro Barbosa, Maria Leticia
    Lima, Lidia Moreira
    Tesch, Roberta
    Sant'Anna, Carlos Mauricio R.
    Totzke, Frank
    Kubbutat, Michael H. G.
    Schaechtele, Christoph
    Laufer, Stefan A.
    Barreiro, Eliezer J.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 71 : 1 - 14
  • [7] Synthesis and structure-activity relationships of boswellic acid derivatives as potent VEGFR-2 inhibitors
    Shen, Sida
    Xu, Xingyu
    Liu, Zhulong
    Liu, Junhua
    Hu, Lihong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1982 - 1993
  • [8] A Review on Fused Pyrimidine Systems as EGFR Inhibitors and Their Structure-Activity Relationship
    Yadav, Tanuja T.
    Moin Shaikh, Gulam
    Kumar, Maushmi S.
    Chintamaneni, Meena
    Yc, Mayur
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [9] Structure-Activity Relationship of Substituted Pyrazoline Derivatives as Small Molecule Tyrosine Kinase Inhibitors
    Akbar, Saleem
    Das, Subham
    Mahto, Aman Kumar
    Dewangan, Rikeshwer Prasad
    Ahmed, Bahar
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [10] Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase
    Yu, Bing
    Tang, Li-da
    Li, Yi-liang
    Song, Shu-hui
    Ji, Xiao-liang
    Lin, Mu-sen
    Wu, Chun-Fu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 110 - 114
12345